Alnylam Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

22.11.19	Alnylam Expects To Exceed 2020 Goals With Four Marketed Products (RTTNews)
11.11.19	LPCN Awaits FDA Word, NKTR On Track, All's Well With Five Prime's FPT155 (RTTNews)
31.10.19	Alnylam Pharma Q3 Loss Narrows On Strong Revenue Growth (RTTNews)
06.08.19	Alnylam Pharmaceuticals Inc. Q2 adjusted earnings Beat Estimates (RTTNews)
06.08.19	ALNY To Face FDA In Feb., PODD Ups Outlook Again, Catalysts Galore For XLRN (RTTNews)
11.07.19	Alnylam Pharma: Jeff Poulton To Succeed Manmeet Soni As CFO Effective Aug. 13 (RTTNews)
01.05.19	Alnylam Pharmaceuticals Inc. Q1 adjusted earnings Beat Estimates (RTTNews)
08.04.19	Regeneron To Invest $800 Mln In Alnylam; To Jointly Develop RNAi Therapeutics (RTTNews)
06.03.19	Alnylam: Givosiran Meets Primary, Majority Secondary Endpoints In Envision Study (RTTNews)
04.03.19	5 Biotechs Awaiting Phase III Trial Data In March (RTTNews)
21.01.19	Alnylam Pharma, Medison Partner To Commercialize RNAi Therapeutics In Israel (RTTNews)
31.12.18	10 RNA Therapeutics Companies To Watch In 2019 (RTTNews)
10.12.18	Alnylam Pharma Resolves Litigation With Silence Therapeutics - Quick Facts (RTTNews)
06.12.18	Alnylam Pharma Announces Pipeline Goals For 2019 - Quick Facts (RTTNews)
26.11.18	Vir Biotechnology, Alnylam Start Phase 1/2 Study Of VIR-2218 - Quick Facts (RTTNews)
07.11.18	Alnylam Pharmaceuticals Inc. Q3 adjusted earnings Beat Estimates (RTTNews)
15.10.18	Alnylam Plans To Pursue Full Approval Of Givosiran, Rolling Submission Of NDA (RTTNews)
03.10.18	Alnylam Pharma Submits CTA To Initiate Phase 1/2 Study Of ALN-AAT02 (RTTNews)
28.09.18	Alnylam Announces Submission Of NDA In Japan For ONPATTRO - Quick Facts (RTTNews)
27.09.18	Alnylam Reports Positive Result From Interim Analysis Of Phase 3 Givosiran Study (RTTNews)
24.09.18	Alnylam Pharma: Health Canada Grants Priority Review To Patisiran - Quick Facts (RTTNews)
28.08.18	TLRY On Fire, CRON Up 94% This Month, ALNY Abuzz, RCUS Turns Heads (RTTNews)
21.08.18	Alnylam Pharma Completes Enrollment In Envision Phase 3 Study Of Givosiran (RTTNews)
14.08.18	MBIO & Bubble Boy Disease Gene Therapy, Busy Months Ahead For EIGR, UMRX (RTTNews)
10.08.18	FDA Approves Alnylam's Rare Disease Drug (RTTNews)
04.08.18	Week Ahead In Pharmaceuticals - 10 Stocks To Watch (ALNY, INSM, PRTK...) (RTTNews)
02.08.18	Alnylam Pharmaceuticals Inc. Q2 adjusted earnings Beat Estimates (RTTNews)
30.07.18	European Medicines Agency's CHMP Says Yes To 7 Drugs, No To 1 (RTTNews)
26.07.18	Biotech Stocks Facing FDA Decision In August (RTTNews)
08.06.18	Alnylam Reports Updated Positive Results From Phase 1/2 Study Of Lumasiran (RTTNews)
03.05.18	Alnylam Pharmaceuticals Inc. Q1 adjusted earnings Beat Estimates (RTTNews)
03.05.18	Alnylam Reports Alignment With FDA On Accelerated Development Path For Lumasiran (RTTNews)
23.04.18	Alnylam Reports EMA COMP Positive Opinion For ALN-TTRsc02 - Quick Facts (RTTNews)
21.04.18	Alnylam In Deal With Dicerna Resolving Trade Secret Misappropriation, Other Suit (RTTNews)
16.04.18	ALNY On Watch, NLNK Exhibits Caution, Keep An Eye On GKOS (RTTNews)
08.04.18	An Ear To The Pharma: 9 Stocks To Watch This Week (SELB, AGLE, BPMC, MNOV…) (RTTNews)
03.04.18	Will These Drugs Reach Blockbuster Status? (RTTNews)
03.04.18	RSLS Deflated, ALKS Depressed, ALNY On Watch (RTTNews)
28.03.18	Alnylam: Patisiran Shows Improvement Of Cardiomyopathy In APOLLO Phase 3 Study (RTTNews)
26.03.18	Alnylam Pharma Reports PRIME Designation For Lumasiran - Quick Facts (RTTNews)
25.03.18	An Ear To The Pharma: 5 Stocks To Watch This Week (RTTNews)
22.03.18	FENC On Fast Track, SPHS To Report Data In Q2, REGN, ALNY Team Up For NASH (RTTNews)
21.03.18	Regeneron and Alnylam Pharmaceuticals Announce Collaboration to Discover New Treatments for Nonalcoholic Steatohepatitis (NASH) (PR Newswire)
08.02.18	EARNINGS SUMMARY: Details of Alnylam Pharmaceuticals Inc. Q4 Earnings Report (RTTNews)
02.02.18	AGN's Superbug Antibiotic Gets FDA Nod, AFMD Soars, Boxed Warning For Ocaliva (RTTNews)
08.01.18	CELG Makes Blockbuster Purchase, MDXG, NBIX On Watch, Busy Year Ahead For ALNY (RTTNews)
08.01.18	Sanofi And Alnylam Restructure RNAi Therapeutics Rare Disease Alliance (RTTNews)
18.12.17	Sanofi, Alnylam Submit MAA To European Medicines Agency For Patisiran (RTTNews)
18.12.17	FDA Nod For ACRS, PETX Disappoints, QGEN & OXFD Make Peace, SGRY Fitter (RTTNews)
15.12.17	Alnylam Pharma Announces FDA's Decision To Lift Clinical Hold On Fitusiran (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

UBS Group	28.46	2.63 %	K V
Swiss Life Hldg	712.60	1.86 %	K V
Part Grp Hldg	1’245.50	1.26 %	K V
Zurich Insur Gr	545.00	1.15 %	K V
Swiss Re	132.70	1.14 %	K V
Givaudan	3’945.00	-0.53 %	K V
Geberit	511.20	-0.66 %	K V
Alcon	76.38	-0.68 %	K V
Sika	212.90	-1.34 %	K V
CieFinRichemont	134.25	-2.65 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Alnylam Pharmaceuticals Inc.

Aktien Top/Flop

Meistgelesene Nachrichten